Corrigendum to “TREX1 activators: A novel therapeutic strategy for rheumatoid arthritis management via cfDNA clearance” [Pharmacol. Res. 218 (2025) 107817]
Fields of Study & Subjects
Rheumatoid Arthritis Research and Therapies
Systemic Lupus Erythematosus Research
Natural Compounds in Disease Treatment
Publication details
- Journal / source
- Pharmacological Research
- Volume
- 224
- Pages
- 108093–108093
- Publication date
- 12 January 2026
- Language
- EN